Literature DB >> 17072445

Diacerhein versus glucosamine in a rat model of osteoarthritis.

Márcia Uchôa de Rezende1, Henrique Melo de Campos Gurgel, Paulo Roberto Vilaça Junior, Rogério Kawassaki Kuroba, Alex Silva Santiago Lopes, Renée Zon Phillipi, Arnaldo José Hernandez.   

Abstract

PURPOSE: The purpose of this study was to compare the chondroprotective effect of diacerein and glucosamine regarding degenerative changes and articular stiffness in an experimental model of arthritis.
METHODS: Twenty rats underwent medial meniscectomy on the right knee. Ten animals were given diacerhein, and 10 were given glucosamine, from day 1 to the third month postoperatively, when all of them were killed. Histological and functional analysis of the knees were performed (measurement of maximum extension).
RESULTS: All operated knees showed more limited extension values and more degenerative changes as compared to nonoperated contralateral sides. A comparison of the two drugs showed that the degree of articular stiffness was significantly lower with diacerein, although degenerative changes were similar.
CONCLUSIONS: 1) Prophylactic use of diacerein leads to lower degree of articular stiffness when compared to glucosamine; 2) The prophylactic chondroprotective effects of diacerein and glucosamine are histologically similar.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17072445     DOI: 10.1590/s1807-59322006000500014

Source DB:  PubMed          Journal:  Clinics (Sao Paulo)        ISSN: 1807-5932            Impact factor:   2.365


  8 in total

1.  Effect of Polycalcium, a mixture of Polycan and calcium lactate-gluconate in a 1:9 weight ratio, on rats with surgery-induced osteoarthritis.

Authors:  Jae-Suk Choi; Hyun-Soo Shin; Ki Young Kim; Sae Kwang Ku; In Soon Choi; Joo Wan Kim
Journal:  Exp Ther Med       Date:  2015-03-04       Impact factor: 2.447

2.  Comparison of various SYSADOA for the osteoarthritis treatment: an experimental study in rabbits.

Authors:  María Permuy; David Guede; Mónica López-Peña; Fernando Muñoz; José-Ramón Caeiro; Antonio González-Cantalapiedra
Journal:  BMC Musculoskelet Disord       Date:  2015-05-20       Impact factor: 2.362

3.  Effects of diacerein on cartilage and subchondral bone in early stages of osteoarthritis in a rabbit model.

Authors:  María Permuy; David Guede; Mónica López-Peña; Fernando Muñoz; Jose-Ramón Caeiro; Antonio González-Cantalapiedra
Journal:  BMC Vet Res       Date:  2015-07-02       Impact factor: 2.741

4.  Protective effect of zoledronic acid on articular cartilage and subchondral bone of rabbits with experimental knee osteoarthritis.

Authors:  Guorong She; Ziqi Zhou; Zhengang Zha; Fei Wang; Xiaoting Pan
Journal:  Exp Ther Med       Date:  2017-09-19       Impact factor: 2.447

5.  Effects of Balneotherapy in Jeju Magma-Seawater on Knee Osteoarthritis Model.

Authors:  Choong-Gon Kim; Dae-Geon Lee; Jina Oh; Youn-Ho Lee; Young Joon Lee; Phil Hyun Song; Chang-Hyun Song; Sae-Kwang Ku
Journal:  Sci Rep       Date:  2020-04-20       Impact factor: 4.379

6.  Stress degradation studies and development of a validated stability-indicating-assay-method for determination of diacerein in presence of degradation products.

Authors:  Purnima Hamrapurkar; Priti Patil; Masti Desai; Mitesh Phale; Sandeep Pawar
Journal:  Pharm Methods       Date:  2011-01

Review 7.  Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO.

Authors:  Karel Pavelka; Olivier Bruyère; Cyrus Cooper; John A Kanis; Burkhard F Leeb; Emmanuel Maheu; Johanne Martel-Pelletier; Jordi Monfort; Jean-Pierre Pelletier; René Rizzoli; Jean-Yves Reginster
Journal:  Drugs Aging       Date:  2016-02       Impact factor: 3.923

8.  Anti-Osteoarthritic Effects of a Mixture of Dried Pomegranate Concentrate Powder, Eucommiae Cortex, and Achyranthis Radix 5:4:1 (g/g) in a Surgically Induced Osteoarthritic Rabbit Model.

Authors:  Beom-Rak Choi; Su-Jin Kang; Jong-Lae Kim; Young-Joon Lee; Sae-Kwang Ku
Journal:  Nutrients       Date:  2020-03-22       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.